Summary
Definition
History and exam
Key diagnostic factors
- cough with purulent sputum
- fever
Other diagnostic factors
- headache
- nausea and vomiting
- confusion
- depressed consciousness
- cutaneous ulcers or abscesses
Risk factors
- solid organ and hematopoietic stem cell transplant recipients
- HIV-positive and low CD4 T-cell count (<100 cells/mm³)
- immunosuppression
- structural pulmonary disease
- malignancy and chemotherapy
- agricultural work
Diagnostic tests
1st tests to order
- Gram and acid-fast stains
- culture
- matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)
- biochemical species typing
- polymerase chain reaction (PCR)-based techniques
- chest x-ray
- CT head
Tests to consider
- thoracic CT scan
- MRI head
Emerging tests
- next-generation sequencing
Treatment algorithm
severe nocardiosis: disseminated disease, CNS involvement, cavitary pulmonary lesions, or immunocompromise
nonsevere nocardiosis: immunocompetent, nondisseminated, no CNS involvement, no pulmonary cavitary lesions
Contributors
Authors
Timothy Sullivan, MD
Associate Professor
Division of Infectious Diseases
Icahn School of Medicine at Mount Sinai
New York
NY
Disclosures
TS declares that he has no competing interests.
Acknowledgements
Dr Timothy Sullivan would like to gratefully acknowledge Dr Jorge Garbino and Dr Juan Ambrosioni, previous contributors to this topic.
Disclosures
JG declares that he has no competing interests. JA is an advisory board member of Gilead Sciences and ViiV Healthcare.
Peer reviewers
Senu Apewokin, MD
Associate Professor of Medicine
Director, Transplant Infectious Diseases
University of Cincinnati
Cincinnati
OH
Disclosures
SA declares that she has no competing interests.
Rebecca N. Kumar, MD, MS
Assistant Professor of Medicine
Georgetown University Medical Center
Washington
DC
Disclosures
RNK has received research grants from Regeneron and Gilead, which have been paid to Georgetown University.
References
Key articles
Brown-Elliott BA, Brown JM, Conville PS, et al. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006 Apr;19(2):259-82.Full text Abstract
Hamdi AM, Fida M, Deml SM, et al. Retrospective analysis of antimicrobial susceptibility profiles of Nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017. Antimicrob Agents Chemother. 2020 Feb 21;64(3):e01868-19.Full text Abstract
Corti ME, Villafane-Fioti MF. Nocardiosis: a review. Int J Infect Dis. 2003 Dec;7(4):243-50.Full text Abstract
Margalit I, Lebeaux D, Tishler O, et al. How do I manage nocardiosis? Clin Microbiol Infect. 2021 Apr;27(4):550-8.Full text Abstract
Restrepo A, Clark NM, Infectious Diseases Community of Practice of the American Society of Transplantation. Nocardia infections in solid organ transplantation: guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clin Transplant. 2019 Sep;33(9):e13509. Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Tuberculosis
- Actinomycosis
- Lung abscess
More DifferentialsGuidelines
- Nocardia infections in solid organ transplantation
More GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer